久操视频网站,又大又粗又黄又刺激的免费视频,亚洲三级电影在线播放,国产亚洲视频在线观看二区

中文
中文

以患者需求為核心,驅動細胞免疫治療創(chuàng)新,實現(xiàn)癌癥可控化并最終治愈。

We strive to make patients-driven cellular immunotherapy innovation, to transform cancer into a manageable condition — and ultimately cure it.

2020
  • 0
Potential lung attack and lethality generated by EpCAM-specific CAR-T cells in immunocompetent mouse models.
OncoImmunology 9(1):1806009. (*: Corresponding authors, PMCID: PMC7458607)
Qin D., Li D., Zhang B., Chen Y., Liao X., Li X., Alexander P.B., Wang Y.,* Li Q.-J.* (2020)


T cell receptor repertoire as a prognosis marker for heat shock protein peptide complex-96 vaccine trial against newly diagnosed glioblastoma.
OncoImmunology, 9(1):1749476. (PMCID: PMC7153824)
Zhang Y., Mudgal P., Wang L., Wu H., Huang N., Alexander P.B., Gao Z., Ji N. & Li Q.-J. (2020)
03.23
2022
來源:
關鍵詞:
相關閱讀

Copyright ? 2019 天科雅生物醫(yī)藥科技有限公司

粵公網(wǎng)安備 44011502000528號

粵ICP備20056630號 Powered by vancheer
關于天科雅
研究與發(fā)展
產品及臨床
新聞與媒體

Copyright ? 2019 天科雅生物醫(yī)藥科技有限公司

粵公網(wǎng)安備 44011502000528號

粵ICP備20056630號 Powered by vancheer